|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Net premiums earned | |||||
| Net investment income | |||||
| Net realized gains (losses) on investments | |||||
| Net unrealized gains on equity securities | |||||
| Fee and other income | |||||
| Total revenues | |||||
| Expenses | |||||
| Loss and loss adjustment expenses incurred | |||||
| Underwriting and certain other operating costs | |||||
| Commissions | |||||
| Salaries and benefits | |||||
| Policyholder dividends | |||||
| Provision for investment related credit loss benefit | |||||
| Total expenses | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Earnings per share | |||||
| Basic | |||||
| Diluted | |||||
| Shares used in computing earnings per share | |||||
| Basic | |||||
| Diluted | |||||
| Special cash dividends declared per common share | |||||
| Cash dividends declared per common share |
Loading...
